Real-time Estimate Cboe Europe 10:29:16 2024-06-05 am EDT 5-day change 1st Jan Change
80.88 CHF +1.28% Intraday chart for Alcon Inc. +0.82% +22.88%
Sales 2024 * 9.99B 8.93B Sales 2025 * 10.66B 9.53B Capitalization 44.38B 39.67B
Net income 2024 * 930M 831M Net income 2025 * 1.2B 1.08B EV / Sales 2024 * 4.74 x
Net Debt 2024 * 3B 2.68B Net Debt 2025 * 1.73B 1.54B EV / Sales 2025 * 4.32 x
P/E ratio 2024 *
48.8 x
P/E ratio 2025 *
39.2 x
Employees 25,000
Yield 2024 *
0.32%
Yield 2025 *
0.37%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.28%
1 week+0.82%
Current month+0.40%
1 month+11.26%
3 months+7.15%
6 months+27.99%
Current year+22.88%
More quotes
1 week
79.44
Extreme 79.44
81.22
1 month
71.60
Extreme 71.6
83.34
Current year
62.24
Extreme 62.24
83.34
1 year
61.28
Extreme 61.28
83.34
3 years
55.22
Extreme 55.22
83.34
5 years
38.63
Extreme 38.625
83.34
10 years
38.63
Extreme 38.625
83.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-06-05 80.66 +1.00% 213 016
24-06-04 79.86 -0.18% 568,032
24-06-03 80 -0.42% 762,706
24-05-31 80.34 +0.17% 6,341,942
24-05-30 80.2 +0.25% 759,990

Delayed Quote Swiss Exchange, June 05, 2024 at 10:14 am EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.76 USD
Average target price
93.45 USD
Spread / Average Target
+4.11%
Consensus